Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airways

被引:24
作者
De Boer, J [1 ]
May, F [1 ]
Pouw, H [1 ]
Zaagsma, J [1 ]
Meurs, H [1 ]
机构
[1] Univ Groningen, Ctr Pharm, Dept Mol Pharmacol, NL-9713 AV Groningen, Netherlands
关键词
D O I
10.1164/ajrccm.158.6.9711005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In a guinea pig model of allergic asthma, we have recently established that a deficiency of nitric oxide (MO) contributes to the Increased ex vivo responsiveness of isolated perfused tracheae to methacholine after the early asthmatic reaction at 6 h after inhalational challenge of the animals with ovalburmin aerosol. Because this deficiency could be, caused by a reaction of NO with enhanced levels of inflammation-induced superoxide anion (O-2(-)), we examined the effect of endogenous O-2(-) on the regulation of methacholine-induced constriction by NO of intact perfused tracheal tube preparations from unchallenged (control) guinea pigs and front animals 6 h after ovalbumin challenge, in the presence of the NE synthase (NOS) inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME; 100 mu M) tracheae obtained from unchallenged guinea pigs showed a 1.7-fold increase in the maximal response to intraluminally applied methacholine (p < 0.005). By contrast, the maximal airway response to methacholine was significantly decreased in the presence of the Oz scavenger superoxide dismutase (SOD; 100 U/ml) by approximately 45% (p < 0.01). The SOD-induced decrease in responsiveness to methacholine was reversed by L-NAME. Tracheal preparations obtained at 6 lip after allergen challenge showed a 5.8-fold increased responsiveness to intraluminally applied methacholine compared with controls (p < 0.001) which was not further enhanced in the presence of L-NAME, SOD had neither an effect on the increased responsiveness nor did it restore the potentiating effect of L-NAME. These results indicate that (1) in normoreactive tracheal preparations, the regulatory role of NO is partially counteracted by endogenous O-2(-), and (2) the deficiency of NO in hyperreactive tracheae obtained at 6 tp after ovalbumin challenge Is not caused by ifs reaction with O-2(-), but rather to decreased cNOS activity.
引用
收藏
页码:1784 / 1789
页数:6
相关论文
共 35 条
[1]   REACTIVE OXYGEN SPECIES AND AIRWAY INFLAMMATION [J].
BARNES, PJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 9 (03) :235-243
[2]   NITRIC-OXIDE IS THE ENDOGENOUS NEUROTRANSMITTER OF BRONCHODILATOR NERVES IN HUMANS [J].
BELVISI, MG ;
STRETTON, CD ;
YACOUB, M ;
BARNES, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (02) :221-222
[3]   REVERSAL OF BRONCHOCONSTRICTION BY INHALED NITRIC-OXIDE - HISTAMINE VERSUS METHACHOLINE [J].
BROWN, RH ;
ZERHOUNI, EA ;
HIRSHMAN, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :233-237
[4]   ENHANCED SUPEROXIDE PRODUCTION BY ALVEOLAR MACROPHAGES AND AIR-SPACE CELLS, AIRWAY INFLAMMATION, AND ALVEOLAR MACROPHAGE DENSITY CHANGES AFTER SEGMENTAL ANTIGEN BRONCHOPROVOCATION IN ALLERGIC SUBJECTS [J].
CALHOUN, WJ ;
REED, HE ;
MOEST, DR ;
STEVENS, CA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (02) :317-325
[5]  
CERASOLI F, 1991, AM J RESPIR CELL MOL, V4, P195
[6]  
CHAKDER S, 1991, J PHARMACOL EXP THER, V260, P1113
[7]  
deBoer J, 1996, BRIT J PHARMACOL, V119, P1109
[8]   BRONCHODILATOR ACTION OF INHALED NITRIC-OXIDE IN GUINEA-PIGS [J].
DUPUY, PM ;
SHORE, SA ;
DRAZEN, JM ;
FROSTELL, C ;
HILL, WA ;
ZAPOL, WM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :421-428
[9]   INHIBITION BY L-NG-NITRO-L-ARGININE OF NONADRENERGIC-NONCHOLINERGIC-MEDIATED RELAXATIONS OF HUMAN ISOLATED CENTRAL AND PERIPHERAL AIRWAYS [J].
ELLIS, JL ;
UNDEM, BJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (06) :1543-1547
[10]   Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide [J].
Figini, M ;
Ricciardolo, FLM ;
Javdan, P ;
Nijkamp, FP ;
Emanueli, C ;
Pradelles, P ;
Folkerts, G ;
Geppetti, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :918-923